全文获取类型
收费全文 | 363篇 |
免费 | 55篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 19篇 |
妇产科学 | 9篇 |
基础医学 | 96篇 |
口腔科学 | 9篇 |
临床医学 | 31篇 |
内科学 | 69篇 |
皮肤病学 | 5篇 |
神经病学 | 73篇 |
特种医学 | 30篇 |
外科学 | 22篇 |
综合类 | 5篇 |
预防医学 | 20篇 |
眼科学 | 1篇 |
药学 | 8篇 |
肿瘤学 | 17篇 |
出版年
2021年 | 5篇 |
2016年 | 9篇 |
2015年 | 5篇 |
2014年 | 9篇 |
2013年 | 7篇 |
2012年 | 12篇 |
2011年 | 14篇 |
2010年 | 9篇 |
2009年 | 7篇 |
2008年 | 10篇 |
2007年 | 17篇 |
2006年 | 9篇 |
2005年 | 10篇 |
2004年 | 5篇 |
2003年 | 5篇 |
2002年 | 6篇 |
2000年 | 6篇 |
1999年 | 8篇 |
1997年 | 7篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1992年 | 8篇 |
1991年 | 4篇 |
1990年 | 11篇 |
1989年 | 4篇 |
1987年 | 6篇 |
1986年 | 8篇 |
1985年 | 9篇 |
1984年 | 5篇 |
1983年 | 6篇 |
1981年 | 8篇 |
1980年 | 5篇 |
1979年 | 5篇 |
1978年 | 7篇 |
1977年 | 4篇 |
1976年 | 5篇 |
1975年 | 5篇 |
1974年 | 6篇 |
1973年 | 8篇 |
1972年 | 10篇 |
1971年 | 6篇 |
1970年 | 7篇 |
1969年 | 7篇 |
1968年 | 4篇 |
1966年 | 4篇 |
1933年 | 13篇 |
1932年 | 13篇 |
1931年 | 7篇 |
1929年 | 5篇 |
1923年 | 4篇 |
排序方式: 共有418条查询结果,搜索用时 31 毫秒
1.
M Kornfeld 《Journal of neuropathology and experimental neurology》1986,45(4):447-462
Granular cell tumors in the cerebral hemispheres are rare and of unknown origin. Two large aggressive cerebral neoplasms composed mainly of granular cells and also containing neoplastic astrocytes were studied histologically, ultrastructurally and immunohistochemically. In both instances, transitional forms between astrocytes and typical granular cells were demonstrated. In the second case which consisted of a central core of typical glioblastoma surrounded by a thick shell of granular cells, the latter spread in a fashion that is characteristic of intrinsic tumors of the central nervous system by forming abundant secondary structures of Scherer, particularly under the pia and around cortical blood vessels. All the evidence indicates that in these two cases granular cells were transformed neoplastic astrocytes. Paradoxically, many granular cells exhibited benign cytological features that belied their malignant nature. 相似文献
2.
Larry E. Davis Mario Kornfeld Herbert S. Mooney Kurt J. Fiedler Kathleen Y. Haaland William W. Orrison Elsa Cernichiari Thomas W. Clarkson 《Annals of neurology》1994,35(6):680-688
For 3 months in 1969 a family in the United States that included a pregnant mother consumed pork containing methylmercury. Children, aged 20, 13, and 8 years and a neonate, developed severe neurological signs. Twenty-two years later, the 2 oldest had cortical blindness or constricted visual fields, diminished hand proprioception, choreoathetosis, and atentional deficits. Magnetic resonance images showed tissue loss in the calcarine and parietal cortices and cerebellar folia. The youngest had quadriplegia, blindness, and severe mental retradation until their deaths. The brain of the 8-year-old who died at age 30 showed cortical atrophy, neuronal loss, and gliosis, most pronounced in the paracentral and parietooccipital regions. The total mercury level in formalin-fixed, left occipital cortex was 1,974 ng/gm as measured by atomic absorption. Regional brain mercury levels correlated with extent of brain damage. A control patient had 38.5 ng of mercury/gm in the occipital cortex. Systemic organs in the patient and a control subject had comparable mercury levels. In mercury-intoxicated rats, we found that only 5 to 10% of total brain mercury was lost by formalin fixation. Brain inorganic mercury in the patient ranged from 82 to 100%. Since inorganic mercury crosses the blood-brain barrier poorly, biotransformation of methyl to inorganic mercury may have occurred after methylmercury crossed the blood-brain barrier, accounting for its persistence in brain and causing part of the brain damage. 相似文献
3.
4.
Non-immune non-activated chicken bone marrow-derived macrophages (BM MØ) killed murine embryonic fibroblasts . Following precultivation for 10–35 days chicken BM MØ had the capacity to destroy normal murine embryonic fibroblasts at effector: target ratios of 10:1 to 1:1. Optimal killing was observed following cocultivation of MØ and fibroblasts for 48–72 hrs. Addition of LPS neither initiated nor potentiated MØ-mediated killing. This study demonstrates that chicken MØ have the capacity to destroy, , cells of phylogenetically distant species, similarly to the ability of murine MØ to kill chicken fibroblasts. It is suggested that vertebrate MØ xenolytic potential is analagous to the capacity of invertebrate phagocytes to destroy xenografts. 相似文献
5.
T W Mittag X Xu H Moshoyiannis P Kornfeld G Genkins 《Clinical immunology and immunopathology》1984,31(2):191-201
Possible causes for the failure of immunoassays to detect anti-acetylcholine receptor activity in serum from confirmed myasthenia gravis (MG) patients were investigated. A more sensitive assay, using Protein A to trap immune complexes (ARIA), was applied to 65 MG sera which were negative in the usual assay and to 42 normal human sera. Normal and negative MG sera had antibody (Ab) activity in the same range (50-70 pM). Titers present in 70% of normal sera appeared to be specific antireceptor antibodies as defined by tests for antigen specificity. Thus, higher sensitivity assays did not improve discrimination of MG from normals. In a second group of 108 MG sera studied, 48 were negative by the usual assay criteria in a rat acetylcholine receptor immunoassay. Further detailed analysis of this negative group showed that 3/48 had IgG3 antibody not detectable in the test, 14/48 had Ab's recognizing human receptor determinants exclusively, 29/48 had toxin blocking Ab's not determined by immunoassays, and 6/48 were negative in all tests. The results indicate that the exclusive occurrence of toxin-blocking antibodies in MG subjects is a major factor contributing to false negatives in the ARIA test. Estimates of the amount of Ab's with this functionality indicated that they are present in very much smaller amounts than other classes of anti-receptor Ab's. Degree of blocking activity in patient serum showed a fair correlation with severity of disease. Thus, blocking antibodies appear capable of causing all degrees of disease severity in the absence of other types of antireceptor Ab's. The development of a sensitive and quantitative in vitro assay for blocking antibodies combined with the usual immunoassay would be a major improvement for a MG diagnostic test, with greater than 94% positivity predicted. 相似文献
6.
Kornfeld J 《Medical world news》1984,25(15):43-4, 48-9, 52-3 passim
7.
Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries 总被引:3,自引:0,他引:3
C. Thorup Mark Kornfeld Joseph M. Winaver Michael S. Goligorsky Leon C. Moore 《Pflügers Archiv : European journal of physiology》1998,435(3):432-434
Nitric oxide (NO) has been implicated as a modulator of the vascular effects of angiotensin II (ANG II) in the kidney. We
used a NO-sensitive microelectrode to study the effect of ANG II on NO release, and to determine the effect of selective inhibition
of the ANG II subtype I receptor (AT1) with losartan (LOS) and candesartan (CAN). NO release from isolated and perfused renal
resistance arteries was measured with a porphyrin-electroplated, carbon fiber. The vessels were microdissected from isolated
perfused rat kidneys and perfused at constant flow and pressure in vitro. The NO-electrode was placed inside the glass collection
cannula to measure vessel effluent NO concentration. ANG II stimulated NO release in a dose-dependent fashion: 0.1 nM, 10 nM
and 1000 nM ANG II increased NO-oxidation current by 85±18 pA (n = 11), 148±22 pA (n = 11), and 193±29 pA (n = 11), respectively. These currents correspond to changes in effluent NO concentration of 3.4±0.5 nM, 6.1±1.1 nM, and 8.2±1.3 nM,
respectively. Neither LOS (1 μM) nor CAN (1 nM) significantly affected basal NO production, but both AT1-receptor blockers
markedly blunted NO release in response to ANG II (10 nM): 77±6% inhibition with LOS (n = 8) and 63±9% with CAN (n = 8). These results are the first to demonstrate that ANG II stimulates NO release in isolated renal resistance arteries,
and that ANG II-induced NO release is blunted by simultaneous AT1-receptor blockade. Our findings suggest that endothelium-dependent
modulation of ANG II-induced vasoconstriction in renal resistance arteries is mediated, at least in part, by AT1-receptor-dependent
NO release.
Received: 24 September 1997 / Accepted: 20 October 1997 相似文献
8.
9.
10.
Estienne V Duthoit C Costanzo VD Lejeune PJ Rotondi M Kornfeld S Finke R Lazarus JH Feldt-Rasmussen U Franke WG Smyth P D'Herbomez M Conte-Devolx B Persani L Carella C Jourdain JR Izembart M Toubert ME Pinchera A Weetman A Sapin R Carayon P Ruf J 《European journal of endocrinology / European Federation of Endocrine Societies》1999,141(6):563-569
OBJECTIVE: TGPO autoantibodies (aAbs) that bind simultaneously to thyroglobulin (Tg) and thyroperoxidase (TPO) are present in the serum of patients with autoimmune thyroid diseases (AITD) and have been found to differ from monospecific Tg and TPO aAbs. To obtain further insights on the prevalence defined as the rate of occurrence and significance of TGPO aAbs in a large population, we carried out a collaborative study involving 15 European teams. METHODS: Serum samples from 3122 patients with various thyroid and non-thyroid diseases and normal subjects were assayed using a novel TGPO aAb detection kit. This test was designed so that TGPO aAbs are trapped between the Tg-coated solid phase and the soluble TPO labeled with a radioiodinated monoclonal antibody. RESULTS: Only three out of the 220 normal subjects (prevalence of 1.4%) were found to have positive TGPO aAb levels, which were mainly observed in the patients with AITD: the group of patients suffering from Hashimoto's thyroiditis had a TGPO aAb prevalence of 40.5% (n=437 patients), those with Graves' disease, a prevalence of 34.6% (n=645) and those with post-partum thyroiditis, 16.0% (n=243). Among the non-AITD patients with positive TGPO aAb levels, the TGPO aAb prevalence ranged from 20.7% among those with thyroid cancer (n=246) to 0% among those with toxic thyroid nodules (n=47). Among the patients with non-thyroid diseases, the TGPO aAb prevalence ranged from 9.8% in the case of Biermer's pernicious anemia (n=78) to 0% in that of premature ovarian failure (n=44). It is worth noting that the groups showing the highest TGPO aAb prevalence also contained the patients with the highest TGPO aAb titers. Statistical comparisons between the TGPO aAb prevalences in the various groups showed that TGPO aAb could be used as a parameter to distinguish between the groups of Hashimoto's and Graves' patients and between the women with post-partum thyroiditis and the post-partum women with only Tg and/or TPO aAb established during early pregnancy. Unexpectedly, the correlations between TGPO aAbs and Tg and TPO aAbs were found to depend mainly on the assay kit used. CONCLUSION: High TGPO aAb titers are consistently associated with AITD but the reverse was not found to be true. TGPO aAbs are a potentially useful tool, however, for establishing Hashimoto's diagnosis, and would be worth testing in this respect with a view to using them for routine AITD investigations. 相似文献